Brian Piper - Jul 20, 2021 Form 4 Insider Report for Prelude Therapeutics Inc (PRLD)

Role
Chief Financial Officer
Signature
/s/ Brian Piper
Stock symbol
PRLD
Transactions as of
Jul 20, 2021
Transactions value $
$0
Form type
4
Date filed
7/22/2021, 06:09 PM
Previous filing
May 27, 2021
Next filing
Aug 27, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRLD Employee Stock Option (Right to Buy) Award $0 +116K $0.00 116K Jul 20, 2021 Common Stock 116K $31.23 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to 25% of the total shares on July 20, 2022, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.